Novartis and Nycomed. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject ...

During his 20-year career in emerging markets, he held country and regional positions at Nycomed, Invida, DKSH, Novartis and Sandoz, working in the proprietary and branded generics pharmaceuticals ...

Propofol sedation by nonanesthesiologists is still a highly controversial issue despite the fact that numerous studies have approved this sedation regimen for gastrointestinal endoscopy. A new ...

Objective Breakthrough cancer pain (BTcP) is common and has a significant impact on the quality of life of patients with cancer. This review compares current national/international BTcP guidelines in ...